Affiliations
AffiliationItem in Clipboard
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto areaChristopher M Booth et al. JAMA. 2003.
. 2003 Jun 4;289(21):2801-9. doi: 10.1001/jama.289.21.JOC30885. Epub 2003 May 6. Authors Christopher M Booth 1 , Larissa M Matukas, George A Tomlinson, Anita R Rachlis, David B Rose, Hy A Dwosh, Sharon L Walmsley, Tony Mazzulli, Monica Avendano, Peter Derkach, Issa E Ephtimios, Ian Kitai, Barbara D Mederski, Steven B Shadowitz, Wayne L Gold, Laura A Hawryluck, Elizabeth Rea, Jordan S Chenkin, David W Cescon, Susan M Poutanen, Allan S Detsky AffiliationItem in Clipboard
Erratum inContext: Severe acute respiratory syndrome (SARS) is an emerging infectious disease that first manifested in humans in China in November 2002 and has subsequently spread worldwide.
Objectives: To describe the clinical characteristics and short-term outcomes of SARS in the first large group of patients in North America; to describe how these patients were treated and the variables associated with poor outcome.
Design, setting, and patients: Retrospective case series involving 144 adult patients admitted to 10 academic and community hospitals in the greater Toronto, Ontario, area between March 7 and April 10, 2003, with a diagnosis of suspected or probable SARS. Patients were included if they had fever, a known exposure to SARS, and respiratory symptoms or infiltrates observed on chest radiograph. Patients were excluded if an alternative diagnosis was determined.
Main outcome measures: Location of exposure to SARS; features of the history, physical examination, and laboratory tests at admission to the hospital; and 21-day outcomes such as death or intensive care unit (ICU) admission with or without mechanical ventilation.
Results: Of the 144 patients, 111 (77%) were exposed to SARS in the hospital setting. Features of the clinical examination most commonly found in these patients at admission were self-reported fever (99%), documented elevated temperature (85%), nonproductive cough (69%), myalgia (49%), and dyspnea (42%). Common laboratory features included elevated lactate dehydrogenase (87%), hypocalcemia (60%), and lymphopenia (54%). Only 2% of patients had rhinorrhea. A total of 126 patients (88%) were treated with ribavirin, although its use was associated with significant toxicity, including hemolysis (in 76%) and decrease in hemoglobin of 2 g/dL (in 49%). Twenty-nine patients (20%) were admitted to the ICU with or without mechanical ventilation, and 8 patients died (21-day mortality, 6.5%; 95% confidence interval [CI], 1.9%-11.8%). Multivariable analysis showed that the presence of diabetes (relative risk [RR], 3.1; 95% CI, 1.4-7.2; P =.01) or other comorbid conditions (RR, 2.5; 95% CI, 1.1-5.8; P =.03) were independently associated with poor outcome (death, ICU admission, or mechanical ventilation).
Conclusions: The majority of cases in the SARS outbreak in the greater Toronto area were related to hospital exposure. In the event that contact history becomes unreliable, several features of the clinical presentation will be useful in raising the suspicion of SARS. Although SARS is associated with significant morbidity and mortality, especially in patients with diabetes or other comorbid conditions, the vast majority (93.5%) of patients in our cohort survived.
Similar articlesFowler RA, Lapinsky SE, Hallett D, Detsky AS, Sibbald WJ, Slutsky AS, Stewart TE; Toronto SARS Critical Care Group. Fowler RA, et al. JAMA. 2003 Jul 16;290(3):367-73. doi: 10.1001/jama.290.3.367. JAMA. 2003. PMID: 12865378
Bitnun A, Allen U, Heurter H, King SM, Opavsky MA, Ford-Jones EL, Matlow A, Kitai I, Tellier R, Richardson S, Manson D, Babyn P, Read S; Other Members of the Hospital for Sick Children SARS Investigation Team. Bitnun A, et al. Pediatrics. 2003 Oct;112(4):e261. doi: 10.1542/peds.112.4.e261. Pediatrics. 2003. PMID: 14523209
Liu CL, Lu YT, Peng MJ, Chen PJ, Lin RL, Wu CL, Kuo HT. Liu CL, et al. Chest. 2004 Aug;126(2):509-17. doi: 10.1378/chest.126.2.509. Chest. 2004. PMID: 15302738 Free PMC article.
Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, Demertzis Z, Hanna Z, Failla A, Dagher C, Chaudhry Z, Vahia A, Abreu Lanfranco O, Ramesh M, Zervos MJ, Alangaden G, Miller J, Brar I. Suleyman G, et al. JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
El-Masri MM, Williamson KM, Fox-Wasylyshyn SM. El-Masri MM, et al. AACN Clin Issues. 2004 Jan-Mar;15(1):150-9. doi: 10.1097/00044067-200401000-00013. AACN Clin Issues. 2004. PMID: 14767372 Review.
Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S; MERS-CoV study group. Guery B, et al. Lancet. 2013 Jun 29;381(9885):2265-72. doi: 10.1016/S0140-6736(13)60982-4. Epub 2013 May 30. Lancet. 2013. PMID: 23727167 Free PMC article.
Wei Y, Lu Y, Xia L, Yuan X, Li G, Li X, Liu L, Liu W, Zhou P, Wang CY, Zhang H. Wei Y, et al. J Med Virol. 2020 Nov;92(11):2758-2767. doi: 10.1002/jmv.26175. Epub 2020 Jul 14. J Med Virol. 2020. PMID: 32544281 Free PMC article.
Darbeheshti F, Abolhassani H, Bashashati M, Ghavami S, Shahkarami S, Zoghi S, Gupta S, Orange JS, Ochs HD, Rezaei N. Darbeheshti F, et al. Adv Exp Med Biol. 2021;1318:91-107. doi: 10.1007/978-3-030-63761-3_6. Adv Exp Med Biol. 2021. PMID: 33973174
de Wit E, van Doremalen N, Falzarano D, Munster VJ. de Wit E, et al. Nat Rev Microbiol. 2016 Aug;14(8):523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27. Nat Rev Microbiol. 2016. PMID: 27344959 Free PMC article. Review.
Oladele JO, Ajayi EI, Oyeleke OM, Oladele OT, Olowookere BD, Adeniyi BM, Oyewole OI, Oladiji AT. Oladele JO, et al. Heliyon. 2020 Sep;6(9):e04897. doi: 10.1016/j.heliyon.2020.e04897. Epub 2020 Sep 9. Heliyon. 2020. PMID: 32929412 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3